The Brief Brief Science
what we just learned about everything.
Science — briefly, then briefly again · tbb.ceo
listen tothe daily 0:00 –:––
/daily ·13 NOV 2026 ·FRIDAY ·2 MIN READ ·6 STORIES

Friday 13 November 2026

Life-threatening mushrooms, in-body CRISPR, and the Ozempic effect reaches kidneys.

01 / The Day

FRIDAY 13 NOV 2026, ranked

06

Florida mushroom pairs psychedelics with lethal toxins

Researchers in Florida identified a brown mushroom that contains both psilocybin-class compounds and amatoxins — the deadly poisons found in death cap mushrooms. It is the first known species to combine hallucinogenic and potentially fatal chemistry.

  • Contains both psilocybin-class compounds and amatoxins from the same fruiting body
  • Amatoxins are responsible for most fatal mushroom poisonings worldwide
  • Raises questions about how such a combined chemical profile could have evolved
Why it mattersAs psychedelic fungi attract clinical and foraging interest, finding one that is also potentially lethal underscores the limits of casual field identification.

In-body CRISPR therapy poised for first FDA approval

A CRISPR therapy that edits genes directly inside the patient, avoiding the costly extract-modify-reinfuse process required by earlier approved therapies, is on track for the first FDA approval of its kind.

  • Edits genes in situ rather than extracting, modifying, and reinfusing patient cells
  • Earlier approved CRISPR treatments require laboratory cell manipulation before return
  • FDA decision would mark a new category of in-vivo gene editing approval
Why it mattersIn-body CRISPR could dramatically reduce the cost and infrastructure requirements of gene therapy, expanding the range of patients who can access it.

RSV vaccines prove their scale: hospitalisations drop sharply

New real-world data show RSV vaccines and monoclonal antibody injections are significantly reducing infections and hospitalisations from respiratory syncytial virus across age groups, with results Nature describes as larger than expected.

  • Both monoclonal antibody injections for infants and adult vaccines showed significant protective effect
  • Hospitalisation reductions are described as larger than projected at rollout
  • RSV vaccines were approved in 2023 for older adults and maternal immunisation programs
Why it mattersRSV historically caused more hospitalisations in infants than flu; confirming the vaccines work at population scale is a public health win with long-term implications.

Granzyme K identified as a driver of quiet organ aging

Aged mice lacking the immune protein granzyme K showed measurably better heart and liver function and less kidney damage than controls, suggesting it drives organ deterioration during normal aging rather than just acting in immune defense.

  • Granzyme K knockout mice had better cardiac, hepatic, and renal function in old age
  • The protein was previously studied for cell-killing roles in immunity, not aging
  • Research published in Nature; human relevance remains to be established
Why it mattersIdentifying a specific protein that accelerates organ aging — rather than merely correlating with it — is rare and points toward a potential therapeutic target.

Semaglutide improves blood vessels and kidney function in patients

Clinical data show that semaglutide, the active ingredient in Ozempic and Wegovy, improved blood vessel function, reduced inflammation, and boosted kidney performance in patients with chronic kidney disease, extending the drug's established cardiovascular benefits to renal health.

  • Semaglutide improved endothelial function and reduced CKD-related inflammation in trial participants
  • Effect seen in patients with pre-existing chronic kidney disease
  • Adds to a growing list of systemic benefits beyond blood sugar and body weight
Why it mattersChronic kidney disease affects 1 in 10 adults worldwide and has few effective treatments; a drug already in mass use showing renal benefit is clinically significant.

Perseverance confirms complex organic carbon in Martian rock

New spectroscopic analysis from NASA's Perseverance rover confirms complex organic carbon compounds preserved in ancient Martian rocks at the Bright Angel formation, suggesting prebiotic chemistry was widespread and stable across Mars's fluvial history.

  • SHERLOC instrument confirmed organics at multiple sites, suggesting widespread distribution
  • Compounds resisted solar and cosmic radiation degradation in shallow strata
  • Published in Science Advances; not evidence of life, but of conditions that could support it
Why it mattersDemonstrating that organic building blocks were widely distributed and stable across Mars substantially strengthens the case for sustained prebiotic chemistry on early Mars.
Be subscriber #028 topic interest list · email delivery not yet available
Past days

The Daily Archive